SCHEMBL2189591

SCHEMBL2189591

CNCCN(C)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3713274 0.86 KDM4A (0.42)
SCHEMBL17721372 0.84
SCHEMBL29736409 0.82 PRMT3 (0.36)
SCHEMBL25415513 0.82 CYP2C9 (0.37)
SCHEMBL27467974 0.82 PRMT3 (0.50)
SCHEMBL13936327 0.80 PRMT3 (0.48)
SCHEMBL179678 0.80
SCHEMBL23728803 0.79 KDM4C (0.38)
SCHEMBL23730577 0.78
Hydrochloric Acid SCHEMBL19924993 0.78 PRMT3 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119462594-A Pradienolide compound and application thereof 卫材R&D管理有限公司 2025-02-18 CN claimed
EP-3642198-B1 SMALL MOLECULE MODULATORS OF HUMAN STING CURADEV PHARMA LTD (GB) 2022-03-16 EP claimed
EP-2914600-A2 FUNCTIONALIZED 9-BROMO-CAMPTOTHECIN DERIVATIVES Nerviano Medical Sciences S.r.l. (IT) 2015-09-09 EP claimed
WO-2014067960-A9 FUNCTIONALIZED 9-BROMO-CAMPTOTHECIN DERIVATIVES NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2015-07-09 WO claimed
WO-2014067960-A2 FUNCTIONALIZED 9-BROMO-CAMPTOTHECIN DERIVATIVES NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2014-05-08 WO claimed
EP-1549655-B1 SUBSTITUTED BICYCLIC THIOPHENE DERIVATIVES, COMPOSTIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK & CO INC (US) 2009-01-21 EP claimed
US-20050239865-A1 Substituted bicyclic thiophene derivatives, compositions containing such compounds and methods of use MERCK SHARP & DOHME CORP. 2005-10-27 US claimed
US-20250288606-A1 POLYMER-CONJUGATED METAP2 INHIBITORS, AND THERAPEUTIC METHODS OF USE THEREOF SYNDEVRX, INC. 2025-09-18 US disclosed
CN-119462594-A Pradienolide compound and application thereof 卫材R&D管理有限公司 2025-02-18 CN disclosed
US-20250019377-A1 1, 4-OXAZEPANE DERIVATIVES AND USES THEREOF JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2025-01-16 US disclosed
EP-4398942-A1 LINKERS FOR USE IN ANTIBODY DRUG CONJUGATES Orum Therapeutics Inc. (KR) 2024-07-17 EP disclosed
US-12037378-B2 Variant CD58 domains and uses thereof NOVARTIS AG (CH) 2024-07-16 US disclosed
US-20240182441-A1 2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE COMPOUNDS ASTRAZENECA AB (SE) 2024-06-06 US disclosed
CN-100439371-C 5, 7-diaminopyrazolo [4, 3-d ] pyrimidines useful in the treatment of hypertension PFIZER LTD (GB) 2008-12-03 CN disclosed
US-20070270412-A1 NOVEL PHARMACEUTICALS PFIZER INC 2007-11-22 US disclosed
US-7262192-B2 Substituted pyrazolo[4,3-d]pyrimidines and their use as PDE-5 inhibitors PFIZER INC. (US) 2007-08-28 US disclosed
US-20050043325-A1 Novel pharmaceuticals PFIZER INC 2005-02-24 US disclosed
US-6479515-B1 FOR THE TREATMENT OF PAIN AND INFLAMMATION, AND ESPECIALLY IN THE TREATMENT OF ASTHMA, CEREBRAL TRAUMATIC SHOCK AND ALLERGIC RHINITIS FOURNIER INDUSTRIE ET SANTE (FR) 2002-11-12 US disclosed
EP-0634996-A1 1,4 NAPHTHOQUINONE DERIVTIVES WITH ANTI-PROTOZOAL AND ANTI-PARASITIC ACTIVITY THE WELLCOME FOUNDATION LIMITED (GB) 1995-01-25 EP disclosed
CN-1083048-A Heterogeneous ring compound WELLCOME FOUND (GB) 1994-03-02 CN disclosed